GlassScriptPhysician profile
Jacquin Coombs
NPI 1346349842
$1,635.56
in general payments reported to CMS, 2019-2025
24 companies · $26.09 in 2025
The $26.09 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $257 · 2021: $293 · 2022: $353 · 2023: $95.20 · 2024: $177 · 2025: $26.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $452.01 | 2019-2022 | |
| Coopersurgical, INC. | $148.98 | 2019-2021 | |
| Astellas Pharma US INC | $133.89 | 2022-2023 | Veozah |
| Myovant Sciences INC. | $111.51 | 2021-2022 | |
| Avion Pharmaceuticals | $104.67 | 2020-2022 | |
| Shield Therapeutics INC | $88.52 | 2022-2024 | Accrufer |
| Pfizer INC. | $83.60 | 2022-2024 | |
| Lupin INC. | $64.75 | 2019-2020 | |
| Shockwave Medical, INC | $49.07 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Therapeuticsmd, INC. | $43.86 | 2019-2020 | |
| Millicent US INC | $41.85 | 2020-2023 | Femring, Intrarosa |
| Acessa Health INC. | $37.66 | 2019 | |
| Evofem Biosciences, INC. | $35.53 | 2021 | |
| Roche Diagnostics Corporation | $31.80 | 2019 | |
| Aspira Women'S Health INC | $26.31 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $26.09 | 2025 | |
| Sumitomo Pharma America, INC. | $25.64 | 2024 | Myfembree |
| Exeltis, USA INC. | $23.33 | 2022 | |
| Exact Sciences Corporation | $20.63 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $20.26 | 2020 | |
| Mylan Pharmaceuticals INC. | $17.44 | 2021 | |
| Hologic Sales and Service, LLC | $17.24 | 2023 | Affirm Prone Biopsy System |
| Sage Therapeutics, LLC | $16.14 | 2024 | |
| Daiichi Sankyo INC. | $14.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquin Coombs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.